​2019 Women in Cancer Research Scholar Awards

Samar Alsafadi, PhD, Institut Curie, Paris, France

Abstract # 3387: Comprehensive detection and analysis of mutant-SF3B1 splice pattern

Poster Session: PO.BSB01.01 - Applications of Cancer Computational Biology 1
Date/Time: April 2, 2019 - 8 a.m. - noon

Justina Caushi, BS, Johns Hopkins University, Baltimore, Maryland

Abstract # 4041: Coupling neoantigen specific T cell clonotypes and their molecular phenotypes at the single cell level in resectable anti-PD-1 treated NSCLC

Poster Session: PO.IM02.09 - Biomarkers and Immune Monitoring
Date/Time: April 2, 2019 - 1 - 5 p.m.

Shanshan Deng, MD, UT MD Anderson Cancer Center, Houston, Texas

Abstract # 2356: Estrogen medicates sex specific function of epithelial STAT3 in K-ras mutant lung tumorigenesis by reprogramming lung tumor microenvironment

Poster Session: PO.IM01.07 - Molecular Mechanisms in the Immune Response to Cancer
Date/Time: April 1, 2019 - 1 - 5 p.m.

Fernanda Faiao-Flores, PhD, Moffitt Cancer Center, Tampa, Florida

Abstract # 378: HDAC inhibition enhances MEK antagonist therapy in uveal melanoma through combined blockade of YAP, AKT and RTK signaling

Poster Session: PO.ET04.02 - New Molecular Targets
Date/Time: March 31, 2019 - 1 - 5 p.m.

Alice Fletcher, PhD, University of Birmingham, Birmingham, UNITED KINGDOM

Abstract # 920: p97/VCP: A novel interactor of the sodium iodide symporter, which can be pharmacologically targeted to increase radioiodine uptake in thyroid and breast cancer cells

Poster Session: MS.EN01.01 - Endocrine-Related Cancer Research
Date/Time: March 31, 2019, 3:20 - 3:35 p.m.

Martha D. Gay, PhD, Georgetown University, Washington, D.C.

Abstract # 2728: Cholecystokinin receptor antagonist proglumide reverses nonalcoholic steatohepatitis and prevents hepatocellular carcinoma

Poster Session: MS.PR01.01 - Molecular and Cellular Mechanisms in Cancer Prevention Research
Date/Time: April 1, 2019 - 1 - 5 p.m.

Eileen Y. Hu, MD, PhD, The Ohio State University College of Medicine, Columbus, Ohio

Abstract # 1541: Evaluation of ROR1 targeted antibody drug conjugate in ROR1 positive leukemia

Poster Session: PO.IM02.17 - Therapeutic Antibodies 2
Date/Time: April 1, 2019 -  8 a.m. - noon

Stephanie LaHaye, PhD, Nationwide Children's Hospital, Columbus, Ohio

Abstract # 1651: Utilization of an ensemble approach for identification of driver fusions in pediatric cancer

Poster Session: PO.BSB01.03 - Laboratory and Computational Methods for Cancer Analysis
Date/Time:  April 1, 2019 -  8 a.m. - noon

Kamira Maharaj, BS, Moffitt Cancer Center, Tampa, Florida

Abstract # 4723: Combinatorial efficacy of anti-PD1 treatment and selective histone deacetylase 6 (HDAC6) inhibition in chronic lymphocytic leukemia (CLL)

Poster Session: PO.ET06.08 - DNA Repair and Reactive Agents / HDAC / Demethylating Agents
Date/Time:  April 3, 2019 -  8 a.m. - noon

Ann Taber, MD, Aarhus University Hospital, Århus N, Denmark

Abstract # 913: Comprehensive molecular characterization of treatment naive muscle invasive bladder cancer

Poster Session: MS.CL11.03 - Biomarkers for Early Detection and Biologic Assessment of Cancer
Date/Time: March 31, 2019 - 1 - 5 p.m.